The company will also present a poster on randomized Phase II data of TG4001 in combination with avelumab in the cervical cancer subgroup. The 2025 American Society of Clinical Oncology (ASCO), annual ...

The United States has seen progress in reducing certain cancer risks, as overall smoking rates remain on a decline.

Cancers caused by the human papillomavirus (HPV) cause result in 6,100 deaths a year in America. HPV vaccination could ...

Details of the presentation are as follows: Title: VERSATILE-003: A Phase 3, Randomized, Open-label Trial of PDS0101 and Pembrolizumab compared with Pembrolizumab for First-Line Treatment of Patients ...